H1B Report
Side-by-side comparison

Frontage Laboratories, Inc. vs INFOSYS LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Frontage Laboratories, Inc.
PARank #FEIN 20-1027574
Entity B
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricFrontage Laboratories, Inc.INFOSYS LIMITED
Total filings311205,263
Certified %85.85%99.55%
Denied %1.93%0.21%
Withdrawn %6.75%0.20%
Cert-withdrawn %5.47%0.05%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePATX

Outcomes — Frontage Laboratories, Inc.

DOL case-status mix.

Outcome breakdown: Certified 85.8%, Cert-withdrawn 5.5%, Withdrawn 6.8%, Denied 1.9%
Outcome breakdown
OutcomeShare
Certified85.8%
Cert-withdrawn5.5%
Withdrawn6.8%
Denied1.9%
Certified85.8%
Cert-withdrawn5.5%
Withdrawn6.8%
Denied1.9%

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Frontage Laboratories, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20109
FY201110
FY20128
FY201316
FY20147
FY201532
FY201619
FY201734
FY201836
FY201928
FY20200
FY20211
FY20220
FY20232
FY202442
FY202539
FY202628
INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558

Top 5 occupations — Frontage Laboratories, Inc.

Top 5 occupations — INFOSYS LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.